2025-03-07 – Press Releases – www.prnewswire.com
Histotripsy is an FDA-approved technology that offers liver cancer patients a non-invasive, painless, and highly effective treatment option HONG KONG, March 7, 2025 /PRNewswire/ — Manulife announced today the extension of its strategic partnership with CUHK Medical Centre (CUHKMC),…
